Celebrities: Are They Helping or Harming the Psychedelic Movement?
Two industry insiders weigh in on the question as more and more of the world’s biggest stars publicly share psychedelic experiences.
Two industry insiders weigh in on the question as more and more of the world’s biggest stars publicly share psychedelic experiences.
In this episode, journalist Ed Prideaux discusses Hallucinogen Persisting Perception Disorder and some of the other very real risks involved with psychedelic misuse.
Journaling is a key practice for integrating psychedelic experiences into our everyday lives, but it’s also an effective analog tool that can help reclaim our lives from the strong pull of the digital world.
Chief Medical Officer Dr. Guy Goodwin clarifies “COMP360 psilocybin therapy was generally well-tolerated” by patients with treatment-resistant depression, despite some adverse reactions from subjects in the study.
In this much anticipated Psychedelic Spotlight podcast, we get to…
Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating with psychedelics.
“If the results are confirmed in subsequent studies … antidepressants may no longer need to be stopped for psilocybin treatment,” says MindMed Executive President Dr. Miri Halperin Wernli.
Ronan Levy, founder of Field Trip Health (NASDAQ: FTRP, TSX:…
A new bill filed in Florida has proposed the decriminalization…
Mixing psychedelics goes by many names in pop culture: hippie flipping (MDMA and mushrooms) and candy flipping (MDMA and LSD), to name two. Depending on how you go about it, the experience can be life-affirmingly euphoric or severely overwhelming. But is it ever worth the risk?
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.